A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Chiu, Chun Hsiang ^a,b   Lee, Yi Tzu ^b,c   Wang, Yung Chih ^a,b   Yin, Ti ^a,b   Kuo, Shu Chen ^b,d   Yang, Ya Sung ^a   Chen, Te Li ^b   Lin, Jung Chung ^a   Wang, Fu Der ^b   Fung, Chang Phone ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Acinetobacter ursingii; Bacteremia; Clinical characteristics; Identification; Minimal inhibitory concentration

Indexed keywords

ANTIINFECTIVE AGENT; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; LEVOFLOXACIN; RNA 16S; RNA 23S;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER URSINGII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MALE; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIOLOGY TEST; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PERFORMANCE; PHENOTYPIC IDENTIFICATION SYSTEM; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; ACINETOBACTER INFECTIONS; DRUG EFFECTS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PHENOTYPE; VERY ELDERLY;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTEREMIA; CEFTAZIDIME; CEFTRIAXONE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; IMIPENEM; INCIDENCE; LEVOFLOXACIN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S;

EID: 84942571400     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1145-z     Document Type: Article

References (28)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
2. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. Manual of clinical microbiology. 2003;8:749-79.
3. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35:2819-25.
4. Humphreys H, Towner KJ. Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland. J Hosp Infect. 1997;37:281-6.
5. List of prokaryotic names with standing in nomenclature. LPSN bacterio.net. http://www.bacterio.net/acinetobacter.html
6. Boo TW, Walsh F, Crowley B. Molecular characterization of carbapenem resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol. 2009;58:209-16.
7. Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen O. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother. 2011;66:738-44.
8. Turton JF, Shah J, Ozongwu C, Pike R. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol. 2010;48:1445-9.
9. Chuang YC, Sheng WH, Li SY, Lin YC, Wang JT, Chen YC, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis. 2011;52:352-60.
10. Schleicher X, Higgins PG, Wisplinghoff H, KörberIrrgang B, Kresken M, Seifert H. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5year period 2005-2009. Clin Microbiol Infect. 2013;19(8):737-42.
11. Wisplinghoff H, Paulus T, Lugenheim M, Stefanik D, Higgins PG, Edmond MB, et al. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect. 2012;64:282-90.
12. Dortet L, Legrand P, Soussy CJ, Cattoir V. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol. 2006;44:4471-8.
13. Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, Van Der Reijden TJ, Dijkshoorn L. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Intl J Sys Evol Microbiol. 2001;51:1891-9.
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
15. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Baltimore, MD: Lippincott Williams and Wilkins; 2004. p. 1659-702.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
17. Chen TL, Siu LK, Wu RC, Shaio MF, Huang LY, Fung CP, et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect. 2007;13:801-6.
18. Kommedal Ø, Karlsen B, Sæbø Ø. Analysis of mixed sequencing chromatograms and its application in direct 16S rRNA gene sequencing of polymicrobial samples. J Clin Microbiol. 2008;46:3766-71.
19. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol. 2005;43:1632-9.
20. Chen TL, Siu LK, Lee YT, Chen CP, Huang LY, Wu RCC, et al. Acinetobacter baylyi as a pathogen for opportunistic infection. J Clin Microbiol. 2008;46:2938-44.
21. Wayne PA. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing: Twenty-first informational supplement. CLSI 2014;M100-S24.
22. Nemec A, Dijkshoorn L, Ježek P. Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens. J Clin Microbiol. 2000;38:3937-41.
23. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148-65.
24. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991;29:277-82.
25. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939-51.
26. Bernards AT, van der Toorn J, van Boven CP, Dijkshoorn L. Evaluation of the ability of a commercial system to identify Acinetobacter genomic species. Eur J Clin Microbiol Infect Dis. 1996;15:303-8.
27. Van Dessel H, Kamp-Hopmans TEM, Fluit AC, Brisse S, De Smet AMGA, Dijkshoorn L, et al. Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J Hosp Infect. 2002;51:89-95.
28. Kishii K, Kikuchi K, Matsuda N, Yoshida A, Okuzumi K, Uetera Y, et al. Evaluation of matrixassisted laser desorption ionizationtime of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures. Clin Microbiol Infect. 2014;20(5):424-30.